Lexaria Bioscience raises about $5.9 million via warrant exercise
Lexaria Bioscience secured about $5.9 million gross proceeds after holders exercised 453,969 existing warrants at $12.92 per share under inducement offer letters. The company will issue new unregistered Series A and Series B warrants.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.